Abstract
Although interferon (IFN) has been used in elderly patients with acute lymphoblastic leukemia (ALL), the benefits from IFN therapy have not been properly assessed, especially as it was given combined with other cytotoxic drugs, which obscured the role of IFN if any. In 1997, we started a study aimed at improving our previous results in elderly patients with ALL and at assessing the therapeutic role of IFN in this disease. Fifty-eight patients with ALL, aged 55-81 years (median: 64.9 years), were randomly allocated to treatment with vindesine or vincristine during induction. After a first consolidation course, IFN was administered as a single agent for three months together with cranial radiotherapy. Chemotherapy was then resumed with a second consolidation course and maintenance. A complete remission (CR) was obtained in 58% of patients (CI: 45-71%), significantly less than in our previous study which included IFN combined with chemotherapy during maintenance (CR: 85%, CI:70-94%, p = 0.007). Overall survival (median: 289 vs 434 days in the previous study, p = 0.01) and disease-free survival (median: 146 vs 427 days, p = 0.009) were also inferior in the present study. In particular, the pattern of relapses over time suggested th...Continue Reading
References
Mar 31, 1990·Lancet·S EinhornM Björkholm
May 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J OchsA I Freeman
Aug 1, 1990·European Journal of Haematology·A DelannoyG Sokal
Sep 1, 1994·British Journal of Haematology·H M KantarjianM J Keating
Dec 1, 1994·Annals of Hematology·E Späth-SchwalbeH Heimpel
Jul 1, 1994·Cancer·S J LauerG R Buchanan
May 1, 1993·Hematological Oncology·J F VirgilioH Saba
Oct 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D FièreF Rigal-Huguet
Jul 1, 1996·Leukemia & Lymphoma·R BassanT Barbui
Jun 1, 1997·British Journal of Haematology·O LegrandR Zittoun
Sep 26, 1997·Leukemia·A DelannoyD Fière
May 20, 1999·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·E NaguraH Saito
Feb 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H M KantarjianE J Freireich
Citations
Jan 14, 2003·Hematological Oncology
Jul 14, 2006·Leukemia·A DelannoyX Thomas
Sep 24, 2004·Drugs & Aging·Tadeusz Robak
Sep 15, 2011·Drugs & Aging·Philippe Rousselot, André Delannoy
Oct 26, 2010·Haematologica·Mathilde Hunault-BergerUNKNOWN Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL)
Nov 8, 2006·European Journal of Haematology·Juan-Manuel SanchoUNKNOWN PETHEMA Group
Mar 15, 2005·Hematology·Roch HouotXavier Thomas
Apr 6, 2004·Leukemia & Lymphoma·Livio PaganoGiuseppe Leone
May 16, 2013·Blood·Nicola Gökbuget
Jan 11, 2007·Blood·Marco VignettiFranco Mandelli
Feb 25, 2009·Expert Opinion on Pharmacotherapy·Xavier Thomas
Oct 22, 2011·The Korean Journal of Internal Medicine·Dong-Yeop ShinByoung-Kook Kim
Dec 20, 2017·Drugs & Aging·Nicola Gökbuget
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bin GaoSvetlana Radaeva
Aug 31, 2016·Oncotarget·Josephine F TrottRobert H Weiss
Jan 8, 2016·Journal of Virology·V MartínN Sevilla
Sep 15, 2015·The Cochrane Database of Systematic Reviews·Yongjun WangCynthia H Seow
Oct 25, 2011·PloS One·Roman A SiddiquiUlrike Sauermann
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N SinghUNKNOWN AST Infectious Diseases Community of Practice
Apr 10, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Carolyn M NielsenEleanor M Riley
Dec 4, 2016·Hematology·Nicola Gökbuget
Apr 16, 2005·World Journal of Gastroenterology : WJG·Xiao-Yu YinMing Kuang
Jun 13, 2017·Leukemia & Lymphoma·Ankit KansagraMark Litzow
Apr 14, 2018·Case Reports in Hematology·Elan GorsheinMecide Gharibo